Company / Cost of Revenue
Natera, Inc. Cost of Revenue History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$39.1M
FY2018
5-year range
-
FY2016-FY2018
Trend
-71.2%
vs FY2017
Sector context
#108 of 113
Health Care
What the data says
Among 113 Health Care companies, Natera, Inc. is in the top 4% for cost of revenue. Improved from $134M to $39M over the past 2 years.
Based on SEC 10-K filings.
$39M in FY2018.
Improved from $134M to $39M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 113This company $39.1M Sector average $11.3B
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2018, cost of revenue decreased 71.2% year-over-year.
- Ranks #108 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $39.1M | -71.2% |
| FY2017 | $135.5M | +0.8% |
| FY2016 | $134.5M | +19.2% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026